Logo 468


Job section - 468
Life science living (section headline)

High blood pressure during pregnancy increases risk of heart disease

High blood pressure during pregnancy increases the risk for cardiovascular disorders later in life, according to a study by...


Calls to unite life science sector

Pharmaceutical giant AstraZeneca stretched out a hand for collaboration with the region’s smaller medicine companies...


‘Promising’ companies disappear

Ten years ago, Göteborgs-Posten listed 30 very promising life science companies in the Gothenburg region. Today, only...


Unique robotic arm to help amputees

<br /><span class=\

The world’s first implantable robotic arm that is directed by thoughts is being developed by a researcher at Chalmers...


AstraZeneca collaborates with academia

Anglo-Swedish pharmaceutical company AstraZeneca has made available a number of potential new drugs free of charge to the...


Gothenburg professor wins Pioneer Award

Mikael Kubista, a Czech professor who runs a gene technology company in Gothenburg, has been named Pioneer of the Year for...


Unique uterus transplantation

Doctors in Gothenburg have carried out the world’s first mother-to-daughter uterus transplants. Two Swedish women,...


Astra Tech stays in Mölndal

Astra Tech will remain in Mölndal. The new owners have decided to not move the operations.

Astra Tech was sold by...


AstraZeneca unions positive to new CEO

The unions at AstraZeneca in Mölndal are positive to the appointment of Frenchman Pascal Soriot as new Group CEO.


AstraZeneca appoints new CEO

Pascal Soriot (press image)

Pharmaceutical giant AstraZeneca has announced that Frenchman Pascal Soriot will be its new chief executive officer...


AstraZeneca: EC approves new antibiotic

AstraZeneca says that Zinforo, a new treatment for serious skin infections and community acquired pneumonia, has been...


AstraZeneca sells drug rights to Pfizer

$250 million. AstraZeneca says it has agreed to sell the rights to market an over-the-counter version of its popular...


Vitrolife receives entrepreneurship award

Vitrolife and Renew Group receive the Göteborg Companipris award of 2012. The award is handed out by the Trade and...


New treatment for alcoholism

Researchers in Sweden say they have found a potential treatment for alcohol dependence.

The drug candidate, OSU6162, was...


Gene discovery can help prevent broken bones

Scientists have identified a specific gene that regulates bone density and strength. The breakthrough can lead to the...


Collaborative project to improve safety of vaccines

Researchers in Gothenburg are taking part in a large EU project to help discover and develop safer vaccines. 30 million...


Successful transplantation of vein grown from human stem cells

In the future it may be possible to create new organs using stem cells from patients, according to scientists in Gothenburg....


Researchers study emergence of resistant bacteria

How can metals and biocides contribute to antibiotic resistance in bacteria? The Sahlgrenska Academy in Gothenburg has...


Vitrolife wins prestigious life science award

Gothenburg company Vitrolife has been named the winner of the 2012 Sweden BIO award...


Researchers plan first mother-daughter uterus transplant

Researchers in Gothenburg are now planning the world's first mother-to-daughter uterus transplants.


US patent approval for Promimic

The Gothenburg-based medical device company Promimic has obtained US patent approval for its thin implant coating HAnano...


Billion dollar acquisition for AstraZeneca

AstraZeneca is acquiring American biotechnology company Ardea Biosciences for 1 billion US dollars, around 6.7 billion...


New Strokefinder ready for clinical study

The first generation of Medfield Diagnostics' supervisory Strokefinder is now ready to be part of a clinical study of...


'Mölndal facility stands strong'

AstraZeneca's Mölndal facility stands strong. This is Karin Wingstrand's, VP and Head of Clinical Development, main...


Broken heart: researchers look for answers

Can you die from a broken heart? Yes, it's possible, but most people survive. A team of heart researchers at the Sahlgrenska...


New collaboration to increase clinical trials

Region Västra Götaland (VGR) wants more clinical trials to take place in the county. It has entered a...


AstraZeneca names Leif Johansson as new chairman

Former Volvo boss Leif Johansson is the proposed next chairman of AstraZeneca. The AstraZeneca board has proposed he takes...


First patients trial cancer vaccine

Gothenburg-based Immunicum has begun phase I/II clinical trials on the first patients for its cancer vaccine.

In total 12...


GU researchers give hope to infertile women

Professor Kui Liu

Researchers at the University of Gothenburg (GU) have made a discovery that could help women who have difficulties...


Mölnlycke buys US Brennen Medical

Med-tech. Gothenburg-based Mölnlycke Health Care has acquired American burn and wound care business Brennen Medical.


Encubator enters new collaboration with AstraZeneca

Business incubator Encubator AB has entered a new collaboration with pharmaceutical giant AstraZeneca. The project, which...


Large study can save many hearts

On Valentine's Day, February 14, begins a large heart study at the Sahlgrenska University Hospital. 1,000 Gothenburgers...


Cultivated corneas - new method in Gothenburg

Cultivated corneas may become reality. Researchers at the University of Gothenburg have been able to grow stem cells on...


Stem cell researcher awarded grant from Brain Foundation

Gothenburg stem cell researcher Charlotta Lindwall has received a research grant for 280,000 kronor from the Swedish Brain...


Life Science a prioritized cluster in West Sweden

The Life Science sector in West Sweden has been identified as one of five prioritized clusters by leading representatives...


10 million kronor to cardiac disease research in Gbg

Three cardiac disease researchers at the Sahlgrenska Academy and the Sahlgrenska Hosptial in Gothenburg have been granted...


International award to Medfield Diagnostics

Gothenburg based life science company Medfield Diagnostics has won an international design award for their stroke helmet,...

Bindhu, Aditi and Vidya

From India to Gothenburg via the UK

A new life in Gothenburg. It is November 2010 and Bindhu Gururajan and Vidya Sudheendara jump on a flight to Gothenburg...


Gothenburg researchers discover new tick-borne infectious disease

Researchers at the Sahlgrenska Academy in Gothenburg have discovered a new tick-borne infectious disease. Only eight cases...


New drug can help insomnia sufferers

A new drug is offering hope to sufferers of insomnia. An extensive clinical trial, which included patients in Gothenburg,...


Brilique listed as major research development

AstraZeneca's new heart-drug, Brilique (ticagrelor tablets) is one of this year's most important research developments,...


AstraZeneca to build factory in China

Pharmaceutical company AstraZeneca will invest around 1.4 billion kronor (200 million dollar), in a new factory in China....


ESC recommends Brilique in new guidelines

AstraZeneca's new heart-drug, Brilique (ticagrelor), has been recommended for treatment of acute coronary syndrome (ACS) by...


AstraZeneca breast cancer drug receives approval in Japan

AstraZeneca's Faslodex 500mg has received regulatory approval in Japan, for the treatment of postmenopausal women with...


Park Annual 2011: innovation, sustainability and democracy

Park Annual is one of the largest life science events in the Gothenburg calendar. The seventh edition of the event took...


French biotech company to buy Cellartis

Gothenburg stem cell company Cellartis announced on Thursday that it is to be acquired by French biotech company Cellectis.


Main partners:

Main Partners (uni collaboration)

Social media:

Linda's twitter logo 2


BRG Expat Guide


Business Region Göteborg

Most read